GlassScriptPhysician profile
Richard I Tsou
NPI 1841365830
$4,693.65
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,216 · 2020: $639 · 2021: $665 · 2022: $783 · 2023: $897 · 2024: $495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,097 · Education: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,097.33 |
| Education | $293.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,625.10 | 2019-2024 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $910.51 | 2019-2024 | Erleada |
| Pfizer INC. | $866.94 | 2019-2024 | |
| Photocure INC | $242.21 | 2019 | |
| Sumitomo Pharma America, INC. | $193.85 | 2023-2024 | Orgovyx |
| Myovant Sciences INC. | $143.97 | 2021-2022 | |
| Abbvie INC. | $143.06 | 2020-2022 | |
| Dornier Medtech America, INC | $104.99 | 2019 | |
| Dendreon Pharmaceuticals LLC | $72.72 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $70.35 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $56.33 | 2022-2023 | Opdivo |
| Ferring Pharmaceuticals INC. | $45.73 | 2019 | |
| Boston Scientific Corporation | $44.61 | 2019 | |
| Amgen INC. | $38.57 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $35.71 | 2023 | Bard Urinary Drainage Bag |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $35.29 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.77 | 2019 | |
| Teleflex LLC | $18.08 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $14.26 | 2022 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Tsou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.